Objectives: A hallmark of human heart failure is prolonged myocardial relaxation. Although the intrinsic mechanism of phospholam-21 ban coupling to the Ca -ATPase is unaltered in normal and failed human hearts, it remains possible that regulation of phospholamban phosphorylation by cAMP-dependent mechanisms or other second messenger pathways could be perturbed, which may account partially for the observed dysfunctions of the sarcoplasmic reticulum (SR) associated with this disease. Methods: cAMP-dependent protein kinase 21 (PKA) and Ca / calmodulin-dependent protein kinase II (CaM kinase) were characterized initially by DEAE-Sepharose chromatography in hearts from patients with end-stage dilated cardiomyopathy. We measured the activity of PKA and CaM kinase in left ventricular tissue of failing (idiopathic dilated cardiomyopathy; ischemic heart disease) and nonfailing human hearts. Results: Basal PKA activity was not changed between failing and nonfailing hearts. One major peak of CaM kinase activity was detected by DEAE-Sepharose chromatography. CaM kinase activity was increased almost 3-fold in idiopathic dilated cardiomyopathy. In addition, hemodynamical data (left ventricular ejection fraction, cardiac index) from patients suffering from IDC positively correlate with CaM kinase activity. Conclusions:
Introduction
binding proteins [3, 4] is thought to be responsible. This is accompanied by reduced b-adrenoceptor agonist-stimu- 21 The regulation of Ca homeostasis in cardiac muscle lated cAMP levels in failing human myocardium [5] . cells is important for contractility and rate of relaxation.
Furthermore, the inotropic effect of b-adrenergic catecholThis is due to phosphorylation of cardiac regulatory amines is reduced in end-stage human heart failure [2] . In 21 proteins like phospholamban (PLB). When phosphorylated addition to these various abnormalities, Ca handling is 21 by PKA or by CaM kinase, PLB releases the cardiac Ca most severely impaired in heart failure [6] . Interestingly, 21 pump (SERCA2a) from inhibition, resulting in an increase the increased resting or end-diastolic Ca content is 21 21 associated with a prolongation of the Ca transient [7] in in Ca transport into cardiac SR-vesicles at low ionized 21 failing human hearts due to both idiopathic dilated carCa concentrations [1] . However, little is known about diomyopathy (IDC) and ischemic heart disease (IHD). The alterations of these mechanisms in end-stage heart failure. 21 Functional studies have revealed that the positive inotropic disturbed Ca handling is associated with abnormalities 21 effect of b-adrenoceptor agonists is reduced in terminal of Ca transport proteins and with quantitative changes in heart failure. This is caused by a multitude of alterations in the expression of regulatory proteins of the SR. Studies of the b-adrenergic pathway. Reduction of the number of mRNA have shown decreased levels for SERCA2a, PLB 21 b-adrenoceptors [2] and an increase of inhibitory GTPand SR-Ca release channel (RyR) in human heart failure [8] [9] [10] [11] . Furthermore, a number of studies have demon- Table 1 human heart failure. In the work described here, we report tissue from nonfailing hearts (NF) that could not be b Drugs used were alcohol, diamorphine and codeine.
transplanted due to surgical reasons (size) or blood group incompatibility was obtained from organ donors. On strated altered SERCA2a and PLB protein levels [12] [13] [14] .
inspection these hearts appeared to have normal ventricles. In contrast, other groups could not detect any changes in Aortic and pulmonary valves were excised and later used the expression of genes encoding SERCA2a, PLB and for valve replacement. Clinical data for these patients are RyR [9, 11, 15] . There are also contradictory data about the reported in Table 1 . Failing hearts were obtained from 21 SR-Ca uptake which is reported to be depressed [10, 16] patients undergoing orthotopic heart transplantation due to or unaltered [17, 18] in human heart failure. Therefore, it is end-stage heart failure (NYHA IV) resulting from IDC or conceivable that additional functional parameters like an IHD. Clinical data are reported in Table 2 . Medical altered activity of regulatory protein kinases are respontreatment for the patients with heart failure consisted of 21 sible for the disturbed Ca homeostasis in end-stage nitrates, cardiac glycosides, diuretics and angiotensin-con- Table 2 Hemodynamic data from patients with end-stage heart failure (NYHA IV) verting enzyme inhibitors. Patients did not receive b-PKA and CaM kinase activity. PKA activity was deadrenoceptor blocking therapy before transplantation. Cartermined by modification of a previously described method diac surgery was performed with neuroleptic narcotic [21] . A 60-mg amount of frozen tissue powder was thawed combination (haloperidol, fentanyl, nitrous oxide). Left and homogenized in 300 ml of buffer A (mM: EDTA, 4; ventricular tissue was quickly transferred in gassed bathing b-mercaptoethanol, 15; pH 7.4) for 3330 s at 48C. The solution [5] at 48C from the operating room to the homogenate was centrifuged for 20 min at 14 000 g. A laboratory. Care was taken not to use scarred, fibrotic, 10-ml aliquot of 2-fold diluted supernatant in buffer A was adipose tissue, endocardium, epicardium or great vessels.
added in 50 ml of assay mixture (with and without 2 mM Tissue was frozen in liquid nitrogen and stored at 2808C cAMP) which contained 30 mM potassium phosphate for biochemical assays. The tissue used for this study was buffer (pH 6.8), 8.3 mg / ml histone IIA, 10 mM MgCl , 5 2 32 frozen within 1.5 h of explantation. mM aminophylline, 0.5 mM ATP and 5 mCi [g P]ATP. Incubation was performed at 308C for 10 min. The reaction 2.2. DEAE-Sepharose chromatography was stopped by addition of 50 ml of 0.2 M EDTA. An 2 aliquot of 20 ml was spotted on 2.532.5 cm P81 Characterization of PKA isozymes was performed simiphosphocellulose papers (Whatman, Maidstone, UK) lar to Corbin et al. [19] . All steps were carried out at 48C.
which were washed three times with 75 mM phosphoric Briefly, 2 g of frozen left ventricular myocardium were acid. Filters were dried and radioactivity was determined homogenized for 3330 s in 10 ml of a buffer containing 1 in a liquid scintillation counter. One unit of PKA activity is mM EDTA and 5 mM Tris-HCl. The homogenate was that amount of enzyme which catalyzes incorporation of 1 32 centrifuged for 20 min at 14 000 g. The clarified supernapmol of P into histone in 1 min. tant was applied to a DEAE-Sepharose column (2.5320
Assays of CaM kinase were performed as described cm, Bio-Rad, Richmond, CA, USA) equilibrated in the previously [22] . The supernatant fraction of human heart same buffer. After washing the column with 60 ml of tissue homogenates was produced as described in debuffer, a linear gradient of NaCl (0 to 0.5 M) was started.
termination of PKA activity. The reaction was started by Fractions of 2 ml volume were collected at a flow-rate of addition of a 10 ml aliquot of 8-fold diluted supernatant in 60 ml / h and the PKA activity determined. A 10-ml aliquot buffer A to 50 ml of a assay mixture containing 10 mM of every second fraction was added to 50 ml of a medium MgCl , 20 mM Tris-HCl (pH 7.4), 20 mM syntide 2, 1 2 (with and without 2 mM cAMP) containing 20 mM NaF, mg / ml bovine serum albumin, 0.1 mM ATP and 5 mCi 3-isobutyl-1-methylxanthine, 0.1 mM ATP and 5 mCi of 1 mM CaCl and 10 mg / ml calmodulin. Ca -in- 2 32 [g P]ATP using histone IIA (8.3 mg / ml) as substrate. dependent protein kinase activity was determined with 5 The assay was carried out as described in Section 2.3. In mM EGTA. In control experiments trifluoperazine (50 addition, protein elution was monitored by the absorbance mM) inhibited CaM kinase activity completely as reported at 280 nm in 10-fold diluted fractions (data not shown).
before in other tissues. Incubation was performed at 308C 32 Characterization of CaM kinase was done by a modifor 5 min. Determination of g P exchange was performed fication of the method of Gupta and Kranias [20] . The left as described above for PKA. The CaM kinase activity is 4. Data analysis tissue was then centrifuged for 20 min at 14 000 g. The resultant supernatant was bound to 10 ml of DEAEData shown are means6S.E.M. Statistical differences Sepharose, which was preequilibrated with the buffer between the different types of myocardium were calculated above (without protease inhibitors). The column (2.5320 by ANOVA followed by Bonferroni's t-test. Correlations cm) was washed with 50 ml of the buffer. The bound were examined by linear regression analysis. P,0.05 was protein was eluted from the column with a linear gradient considered significant. of NaCl (0 to 0.5 M). Fractions (2 ml) were collected at a flow-rate of 60 ml / h. CaM kinase activity was determined in a 10-ml aliquot of every second fraction as described in 2.5. Materials Section 2.3.
32
[g P]ATP was obtained from Hartmann Analytic 2.3. Protein kinase assays (Braunschweig, Germany). Catalytic subunits of PKA, syntide 2, calmodulin and histone IIA were from Sigma All homogenates from nonfailing and failing hearts were (Munich, Germany). Cyclic adenosine 39,59-monophosprepared and assayed in parallel for determination of both phate was obtained from Boehringer Mannheim (Mann-heim, Germany). All other chemicals were of reagent PKA by its ability to phosphorylate histone IIA. Furthergrade.
more, cAMP was able to stimulate protein kinase activity and the specific inhibitor H-8 (data not shown) attenuated the activity. The column was eluted with a NaCl gradient, 3. Results and fractions were assayed for PKA activity in the presence and absence of cAMP. Two peaks of PKA 3.1. Characterization of protein kinases by DEAEactivity were observed. The first peak was eluted with Sepharose chromatography 0.07-0.13 M NaCl, and the second peak with 0.2-0.3 M NaCl. The first and second peaks of PKA activity from Kinase activity was characterized initially in a homogeelution profile are subsequently referred to as types I and II nate of failing left ventricular tissue by DEAE-Sepharose protein kinase, respectively. The proportions of type I and chromatography (Fig. 1A) . The enzyme was identified as type II protein kinase activity were comparable. The elution profile shown for PKA was highly reproducible. A small peak of activity, which is probably the free catalytic subunit, was observed in the flow-through volume of the DEAE-Sepharose column. The activity of the kinase in fractions 37-49 and 49-61 was increased by cAMP, demonstrating that it was PKA activity. We did not perform a separation of PKA isozymes in nonfailing ventricular myocardium because of lack of material.
21
Fig . 1B represents the elution profile of a Ca / calmodulin-dependent protein kinase in a crude extract of heart tissue by DEAE-Sepharose chromatography. The specification of CaM kinase is based on: (1) the kinase phosphorylated the specific substrate syntide 2 [22] . Syntide 2 is a synthetic phosphate acceptor peptide of 15 amino acids; (2) In addition, the enzyme activity was 21 stimulated by 1 mM Ca and 10 mg / ml calmodulin and (3) 5 mM EGTA and 50 mM trifluoperazine inhibited CaM kinase activity almost completely consistent with characterization of the enzyme by others [22] . CaM kinase activity was measured in eluted fractions in absence and 21 presence of Ca and calmodulin. One major peak of CaM kinase was observed, and this activity started to elute with 0.09 M NaCl. Under the conditions of our elution pro- 21 cedure we detected a definite but small peak of Ca / calmodulin-dependent protein kinase activity in the flowthrough volume of fractions 3-13. This activity might be related to the catalytic domain of CaM kinase.
Protein kinase activity in failing and nonfailing hearts
Total PKA activity was measured in homogenized extracts of left ventricular tissue from failing and nonfailing hearts. Basal PKA activity was comparable in all groups: 60.565.6, 68.066.2 and 51.764.3 U / mg in NF (n58), IDC (n510) and IHD (n510), respectively. We inhibits CaM kinase activity completely due to binding of Fig. 2 . CaM kinase activity in homogenized extracts from failing (idiopathic dilated cardiomyopathy, IDC; ischemic heart disease, IHD) and nonfailing (NF) left ventricular myocardium. Extracts were prepared and protein kinase activity was measured as described in Section 2. 21 Ca / calmodulin-dependent kinase activity was measured with syntide 2 21 21 as substrate in the presence of Ca and calmodulin (open bars). Caindependent protein kinase activity was determined with EGTA (hatched bars). Net activity depicts the difference between both activities (solid bars). Number of hearts (n) which were studied are shown below. Data were compared using one-way analysis of variance indicating significant differences between groups. Significance of differences between pairs was tested by Bonferroni t-test. q5a significant difference versus NF. 21 intracellular Ca . Net activity depicts the difference 21 between stimulated and Ca -independent protein kinase suffering from IHD.
Discussion

Relation between myocardial function and CaM kinase activity
4.1. PKA activity in heart failure Hemodynamical data were not significantly different The existence of PKA isozymes in human myocardium between IDC and IHD ( Table 2) . CaM kinase activities has been described first by Corbin and Keely [24] . They were plotted versus the hemodynamic data from patients reported about equal amounts of type I and type II protein with end-stage heart failure due to both IDC and IHD.
kinase in human right atrium. Here, we report for the first There was a close positive correlation between either the time the separation of PKA isozymes in human ventricular left ventricular ejection fraction (Fig. 3A) or the cardiac tissue. Since it is known that the ratio of PKA isozymes index (Fig. 3B) and CaM kinase activity in IDC. We found could have functional consequences [25] , it is conceivable no significant correlation between the increase in CaM that the proportions of isozymes in human ventricle could kinase activity and the pulmonary capillary wedge pressure affect the PKA-mediated phosphorylation of cardiac regin IDC. In addition, the CaM kinase activities in IHD did ulatory proteins. Under the conditions of this work, almost not correlate with the hemodynamic data from patients equal levels of type I and type II PKA were detected in suffering from IHD.
failing ventricular myocardium.
A number of studies have implicated an altered bmechanisms might compensatively trigger an enhanced 21 adrenoceptor signalling pathway as an important factor in activation of the alternative Ca / calmodulin-dependent the initiation and progression of cardiac failure. Despite pathway. Therefore, an increased CaM kinase-dependent many alterations in the b-adrenoceptor signalling pathway phosphorylation of PLB may compensate in part the 21 [2] [3] [4] [5] [26] [27] [28] in our study the basal PKA activity was diastolic Ca accumulation. An enhanced CaM kinaseunchanged between failing and nonfailing hearts. This is in dependent phosphorylation of TnI could promote myocaragreement with results of another group [29] . We conclude dial relaxation by decreasing the affinity of troponin C for 21 that the PKA cannot account for the pathogenesis of Ca ions. A potential phosphorylation of SERCA2a could 21 cardiac failure. hasten the rate of relaxation by stimulating Ca uptake into the SR. Furthermore, it is conceivable that an in- 21 4.2. CaM kinase in the heart creased phosphorylation of RyR may release more Ca ions from the SR during the next systolic contraction, thus 21 21 In order to determine the contribution of the Cacompensating the reduced systolic Ca content in IDC dependent second messenger system in the dysregulation reported. 21 of the intracellular Ca content in heart failure, we have characterized the CaM kinase. The existence of a myocar-4.4. Possible pathophysiological role of CaM kinase 21 dial Ca / calmodulin-dependent protein kinase activity was first observed by Le Peuch et al. [30] and was We suggest here that the increased CaM kinase activity specified as CaM kinase. Kloepper and Landt [31] idenin IDC leads to enhanced CaM kinase-dependent phos- 21 tified two Ca / calmodulin-dependent protein kinase acphorylation states of regulatory proteins which tries to tivities in bovine heart, whereas Gupta and Kranias [20] compensate impaired relaxation in initially developing showed that canine myocardium contains only one type of heart failure due to IDC ( Fig. 3A and B) . In addition, 21 purified membrane-bound Ca / calmodulin-dependent purified myosin light-chain kinase (MLCK) has been protein kinase. Our study shows that DEAE-Sepharose shown to be phosphorylated by CaM kinase [40] . Persechchromatography led, under the conditions described, to the ini et al. [41] have demonstrated that the phosphorylation elution of one peak activity, indicating that human venof skeletal myosin P-light chain by MLCK increases the 21 tricular myocardium contains one type of Ca / calisometric tension. Hence, it is conceivable that CaM kinase modulin-dependent protein kinase.
phosphorylates MLCK more in IDC than in IHD. This would be an additional compensatory mechanism to sus-4.3. Possible physiological role of cardiac CaM kinase tain cardiac output in IDC. The generation of high-energy phosphates (e.g. ATP) declines during severe ischemia and It is established that, in cardiac muscle, CaM kinase is a major reason for contractile dysfunction [42] . If one phosphorylates the inhibitory subunit of troponin (TnI), assumes a higher ATP/ADP ratio in IDC compared to IHD PLB and RyR proteins involved in regulation of cardiac it is likely that this higher ratio and the increased CaM contractility [20, 30, 32, 33] . Controversy exists as to kinase activity result in an increase in the phosphorylation whether or not SERCA2a is a substrate for CaM kinase in of regulatory proteins in IDC versus IHD. Thus, contracvitro and in vivo [34] [35] [36] . At present the role of CaM tility and performance should better correlate to CaM 21 kinase in modulating the Ca handling is poorly underkinase activity in IDC than in IHD, which we observed. stood. Interestingly, we observed an increased CaM kinase activity in left ventricular tissue suffering from IDC. Our data suggest that increased CaM kinase activity in IDC 4.5. Limitations correlates positively with the hemodynamical values, especially EF and CI. In other words, the increase in CaM It could be argued that CaM kinase activation is an kinase activity could represent an early adaptive process of epiphenomenon of cardiac hypertrophy. However, this is the impaired relaxation in human heart failure due to IDC.
rather unlikely because it is only increased in certain kinds The relaxation abnormalities are associated with an inof hypertrophy. Whereas an increase was detected in IDC 21 21 creased diastolic Ca content and a reduced systolic Ca no alteration was noted in IHD. Moreover, a previouś content under basal conditions or b-adrenergic stimulation study by Boknık et al. [43] showed that CaM kinase [6, 37] . The observed alterations are accompanied by activity is unchanged in a rat model of b-adrenoceptorreduced b-adrenoceptor agonist-stimulated cAMP levels in stimulation-induced heart hypertrophy. There is precedent failing human myocardium [5] . In addition, the type 1 for specific biochemical differences between IDC and IHD phosphatase activity is elevated in failing human hearts [27, 38, 44] . It is very unlikely that the medication accounts suffering from IDC [38] . It is conceivable that all these for the differences which we noted in CaM kinase activity alterations may cause a diminished cAMP-dependent between IDC and IHD because in our study almost all phosphorylation of cardiac regulatory proteins which was patients regardless of etiology (IDC / IHD) received drugs shown Bartel et al. [39] . However, at present unknown like glycosides, diuretics and ACE inhibitors. of highly specific DNA-probes for Northern analysis in
